Erik-Jan Kamsteeg

1.9k total citations
21 papers, 874 citations indexed

About

Erik-Jan Kamsteeg is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erik-Jan Kamsteeg has authored 21 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erik-Jan Kamsteeg's work include Ion channel regulation and function (7 papers), Ion Transport and Channel Regulation (5 papers) and Genomics and Rare Diseases (4 papers). Erik-Jan Kamsteeg is often cited by papers focused on Ion channel regulation and function (7 papers), Ion Transport and Channel Regulation (5 papers) and Genomics and Rare Diseases (4 papers). Erik-Jan Kamsteeg collaborates with scholars based in Netherlands, United States and Germany. Erik-Jan Kamsteeg's co-authors include Amy S. Duffield, Michael J. Caplan, Tjitske Kleefstra, Philipp Pagel, Bas W. M. van Balkom, Joris A. Veltman, Michèl A.A.P. Willemsen, Jolanda Schieving, Simone van der Burg and Lotte Krabbenborg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Brain.

In The Last Decade

Erik-Jan Kamsteeg

20 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik-Jan Kamsteeg Netherlands 15 425 320 105 95 84 21 874
Thomas F. Wienker Germany 20 658 1.5× 382 1.2× 171 1.6× 61 0.6× 81 1.0× 59 1.3k
Teresa Esposito Italy 23 660 1.6× 421 1.3× 48 0.5× 172 1.8× 75 0.9× 82 1.4k
Ahmet Okay Çağlayan Türkiye 18 482 1.1× 390 1.2× 115 1.1× 71 0.7× 58 0.7× 79 1.1k
Birgit Zirn Germany 19 689 1.6× 419 1.3× 133 1.3× 100 1.1× 61 0.7× 33 1.1k
Britt Johnson United States 17 451 1.1× 277 0.9× 184 1.8× 80 0.8× 72 0.9× 40 1.0k
Alice Goldenberg France 20 678 1.6× 565 1.8× 124 1.2× 40 0.4× 50 0.6× 49 1.1k
Isabelle Thiffault United States 23 822 1.9× 482 1.5× 224 2.1× 75 0.8× 96 1.1× 65 1.4k
Taila Hartley Canada 20 591 1.4× 674 2.1× 102 1.0× 61 0.6× 150 1.8× 54 1.2k
Alexandra Afenjar France 16 521 1.2× 621 1.9× 106 1.0× 76 0.8× 33 0.4× 42 1.0k
Christel Thauvin‐Robinet France 21 762 1.8× 532 1.7× 155 1.5× 106 1.1× 70 0.8× 80 1.4k

Countries citing papers authored by Erik-Jan Kamsteeg

Since Specialization
Citations

This map shows the geographic impact of Erik-Jan Kamsteeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik-Jan Kamsteeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik-Jan Kamsteeg more than expected).

Fields of papers citing papers by Erik-Jan Kamsteeg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik-Jan Kamsteeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik-Jan Kamsteeg. The network helps show where Erik-Jan Kamsteeg may publish in the future.

Co-authorship network of co-authors of Erik-Jan Kamsteeg

This figure shows the co-authorship network connecting the top 25 collaborators of Erik-Jan Kamsteeg. A scholar is included among the top collaborators of Erik-Jan Kamsteeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik-Jan Kamsteeg. Erik-Jan Kamsteeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachmann, Christoph, Nicol C. Voermans, Erik-Jan Kamsteeg, et al.. (2022). Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies. Brain Communications. 4(5). fcac224–fcac224. 2 indexed citations
2.
Veenstra‐Knol, Hermine E., Fleur Vansenne, Erica H. Gerkes, et al.. (2020). De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability. European Journal of Human Genetics. 28(6). 763–769. 8 indexed citations
3.
Eidhof, Ilse, Jonathan Baets, Erik-Jan Kamsteeg, et al.. (2018). GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia. Brain. 141(9). 2592–2604. 14 indexed citations
4.
Xia, Li, Qiuyun Chen, Walid Fazeli, et al.. (2018). De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca2+ sensitivity. European Journal of Human Genetics. 26(2). 220–229. 41 indexed citations
5.
Régal, Luc, Isabelle Maystadt, Nicol C. Voermans, et al.. (2017). PREPL deficiency: delineation of the phenotype and development of a functional blood assay. Genetics in Medicine. 20(1). 109–118. 24 indexed citations
6.
Vissers, Lisenka E.L.M., Jolanda Schieving, Erik-Jan Kamsteeg, et al.. (2017). A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genetics in Medicine. 19(9). 1055–1063. 168 indexed citations
7.
O’Grady, Gina, Michaela Yuen, Richard Webster, et al.. (2016). Variants in SLC18A3 , vesicular acetylcholine transporter, cause congenital myasthenic syndrome. Neurology. 87(14). 1442–1448. 42 indexed citations
8.
Krabbenborg, Lotte, Lisenka E.L.M. Vissers, Jolanda Schieving, et al.. (2016). Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases. Journal of Genetic Counseling. 25(6). 1207–1214. 73 indexed citations
9.
Blanchard, Maxime G., Marjolein H. Willemsen, Sulayman D. Dib‐Hajj, et al.. (2015). De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. Journal of Medical Genetics. 52(5). 330–337. 103 indexed citations
10.
Voermans, Nicol C., Arie Oosterhof, Gea Drost, et al.. (2012). G.P.103 Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: A review of literature and a cross-sectional clinical study in 17 patients. Neuromuscular Disorders. 22(9-10). 899–899.
11.
Marcelis, Carlo, et al.. (2009). A Feingold syndrome case with previously undescribed features and a new mutation.. PubMed. 20(3). 261–7. 1 indexed citations
12.
Kamsteeg, Erik-Jan, Monique Stoffels, Grazia Tamma, Irene B. M. Konings, & Peter M.T. Deen. (2009). Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus. Human Mutation. 30(10). 1387–1396. 9 indexed citations
13.
Klepper, Jörg, et al.. (2009). Autosomal Recessive Inheritance of GLUT1 Deficiency Syndrome. Neuropediatrics. 40(5). 207–210. 46 indexed citations
14.
Lin, Dao‐Hong, Erik-Jan Kamsteeg, Yan Zhang, et al.. (2008). Expression of Tetraspan Protein CD63 Activates Protein-tyrosine Kinase (PTK) and Enhances the PTK-induced Inhibition of ROMK Channels. Journal of Biological Chemistry. 283(12). 7674–7681. 21 indexed citations
15.
Caplan, Michael J., Erik-Jan Kamsteeg, & Amy S. Duffield. (2007). Tetraspan proteins: regulators of renal structure and function. Current Opinion in Nephrology & Hypertension. 16(4). 353–358. 16 indexed citations
16.
Duffield, Amy S., et al.. (2003). The tetraspanin CD63 enhances the internalization of the H,K-ATPase β-subunit. Proceedings of the National Academy of Sciences. 100(26). 15560–15565. 96 indexed citations
17.
Deen, Peter M.T., Nannette Marr, Erik-Jan Kamsteeg, & Bas W. M. van Balkom. (2000). Nephrogenic diabetes insipidus. Current Opinion in Nephrology & Hypertension. 9(6). 591–595. 40 indexed citations
18.
Deen, P.M.T., Bas W. M. van Balkom, & Erik-Jan Kamsteeg. (2000). Routing of the aquaporin-2 water channel in health and disease. European Journal of Cell Biology. 79(8). 523–530. 37 indexed citations
19.
Dørum, Anne, Pål Møller, Erik-Jan Kamsteeg, et al.. (1997). A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. European Journal of Cancer. 33(14). 2390–2392. 21 indexed citations
20.
Hofstra, Robert M.W., Tineke Stelwagen, Rein P. Stulp, et al.. (1996). Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.. The Journal of Clinical Endocrinology & Metabolism. 81(8). 2881–2884. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas F. Wienker Breakdown of academic impact, for papers by Teresa Esposito Breakdown of academic impact, for papers by Ahmet Okay Çağlayan Breakdown of academic impact, for papers by Birgit Zirn Breakdown of academic impact, for papers by Britt Johnson Breakdown of academic impact, for papers by Alice Goldenberg Breakdown of academic impact, for papers by Isabelle Thiffault Breakdown of academic impact, for papers by Taila Hartley Breakdown of academic impact, for papers by Alexandra Afenjar Breakdown of academic impact, for papers by Christel Thauvin‐Robinet
Rankless by CCL
2026